Fenofibrate [orch, phsu]
Lipid [lipd]
MODIFY [ftcn]
effects [qlco]
Dyslipidaemia [dsyn]
vascular [bpoc]
effects [qlco]
Diabetes Mellitus, Type 2 [dsyn]
Fenofibrate [orch, phsu]
fibric acid [orch, phsu]
Derivative [ftcn]
Lipid [lipd]
MODIFY [ftcn]
effects [qlco]
mediated [socb]
Activation [acty]
peroxisome proliferator activated receptor [aapp, rcpt]
Fenofibrate [orch, phsu]
effects [qlco]
Reducing [qlco]
Levels [qlco]
Fibrinogen [aapp, bacs, phsu]
C-reactive protein [aapp, imft]
Various [irda]
Pro [aapp, bacs]
Inflammatory [ftcn]
Marker [clna]
Improving [qlco]
Flow [npop]
mediated [socb]
Dilatation [topp]
Contribute [acty]
Efficacy [qlco]
Improving [qlco]
Microvascular [ftcn]
effects [qlco]
Fenofibrate [orch, phsu]
Lipid [lipd]
Profile [lbpr]
randomized controlled trials [inpr, resa]
Primary [qlco]
Dyslipidaemia [dsyn]
Fenofibrate [orch, phsu]
Decreased [qnco]
Triglyceride level [lbtr]
Great extent [qlco]
placebo [topp]
increases [ftcn]
High density lipoprotein cholesterol level [lbpr]
reductions [npop]
Low Density Lipoprotein Cholesterol [bacs, strd]
Total Cholesterol [lbpr]
Seen [qlco]
Trial [resa]
Fenofibrate [orch, phsu]
Gemfibrosil [lipd, phsu]
effects [qlco]
High density lipoprotein cholesterol level [lbpr]
Trial [resa]
Total Cholesterol [lbpr]
Reduced [qlco]
Great extent [qlco]
Fenofibrate [orch, phsu]
Gemfibrosil [lipd, phsu]
Fenofibrate [orch, phsu]
High density lipoprotein cholesterol level [lbpr]
Great extent [qlco]
Statin [orch, phsu]
Primary [qlco]
Dyslipidaemia [dsyn]
Statin [orch, phsu]
Decreased [qnco]
Total Cholesterol [lbpr]
Great extent [qlco]
Fenofibrate [orch, phsu]
Fenofibrate [orch, phsu]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Patients [podg]
Metabolic syndrome [dsyn]
Diabetes Mellitus, Type 2 [dsyn]
Reducing [qlco]
Levels [qlco]
High density lipoprotein cholesterol level [lbpr]
Promoting [acty]
Shift [ftcn]
larger [qnco]
low-density lipoprotein particle [celc]
CARDIOVASCULAR [bdsy]
Fenofibrate [orch, phsu]
coronary heart disease [dsyn]
Events [evnt]
Great extent [qlco]
placebo [topp]
Patients [podg]
Type 2 Diabetes [dsyn]
Trial [resa]
Events [evnt]
Myocardial Infarction [dsyn]
Revascularisation [topp]
Certain [qlco]
Microvascular [ftcn]
Amputation [topp]
laser therapy [topp]
Diabetic Retinopathy [dsyn]
progression [patf]
Albuminuria [fndg]
Reduced [qlco]
Great extent [qlco]
Fenofibrate [orch, phsu]
placebo [topp]
subgroup [virs]
Revealed [qlco]
reduction [npop]
Cardiovascular event [fndg]
Fenofibrate [orch, phsu]
Recipient [humn]
subgroup [virs]
Patients [podg]
Marked [qlco]
Hypertriglyceridaemia [fndg]
Marked [qlco]
Dyslipidaemia [dsyn]
baseline [bodm]
accord [socb]
Lipid [lipd]
Trial [resa]
Patients [podg]
Type 2 Diabetes [dsyn]
High Risk [qlco]
cardiovascular events [fndg]
Received [qlco]
Fenofibrate [orch, phsu]
Simvastatin [orch, phsu]
Received [qlco]
placebo [topp]
Plus [qlco]
Simvastatin [orch, phsu]
Primary [qlco]
secondary [neop]
CARDIOVASCULAR [bdsy]
Fenofibrate [orch, phsu]
Simvastatin [orch, phsu]
Benefit [qnco]
Patients [podg]
Markedly [qlco]
Levels [qlco]
Markedly [qlco]
Low density lipoprotein cholesterol level [lbpr]
baseline [bodm]
Addition [ftcn]
Fenofibrate [orch, phsu]
Simvastatin [orch, phsu]
Slow [qlco]
progression [patf]
Diabetic Retinopathy [dsyn]
Fenofibrate [orch, phsu]
Well [qlco]
adverse events [fndg]
included [ftcn]
increases [ftcn]
Transaminase [aapp, enzy]
Levels [qlco]
Transient [popg]
Minor [popg]
Asymptomatic [fndg]
gastrointestinal sign [sosy]
symptoms [ftcn]
Fenofibrate [orch, phsu]
Option [ftcn]
Patients [podg]
Dyslipidaemia [dsyn]
Atherogenesis [patf]
Dyslipidaemia [dsyn]
Characterized [acty]
Low density lipoprotein cholesterol level [lbpr]
